Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 6
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study.
Lee SA, Hong SJ, Sung JH, Kim KS, Kim SH, Cho JM, Chun SW, Lee SR, Kim CS, Kim TN, Kim DH, Park HC, Kim BJ, Kim HS, Choi JY, Hong YJ, Chung JW, Yoon SB, Lee SH, Lee CW. Lee SA, et al. Medicine (Baltimore). 2023 Nov 24;102(47):e36122. doi: 10.1097/MD.0000000000036122. Medicine (Baltimore). 2023. PMID: 38013289 Free PMC article. Clinical Trial.
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study.
Moon JS, Park IR, Kim SS, Kim HS, Kim NH, Kim SG, Ko SH, Lee JH, Lee I, Lee BK, Won KC. Moon JS, et al. Diabetes Metab J. 2023 Nov;47(6):818-825. doi: 10.4093/dmj.2023.0171. Epub 2023 Nov 24. Diabetes Metab J. 2023. PMID: 38043782 Free PMC article. Clinical Trial.
LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes.
Ding J, Nguyen AT, Lohman K, Hensley MT, Parker D, Hou L, Taylor J, Voora D, Sawyer JK, Boudyguina E, Bancks MP, Bertoni A, Pankow JS, Rotter JI, Goodarzi MO, Tracy RP, Murdoch DM, Duprez A, Rich SS, Psaty BM, Siscovick D, Newgard B, Herrington D, Hoeschele I, Shea S, Stein JH, Patel M, Post W, Jacobs D Jr, Parks JS, Liu Y. Ding J, et al. J Clin Invest. 2024 May 15;134(10):e173278. doi: 10.1172/JCI173278. J Clin Invest. 2024. PMID: 38747290 Free PMC article. Clinical Trial.
23 results